CONTEXT: Obesity is characterized by reduced GH secretion, but data regarding IGF-I levels and their determinants are conflicting. OBJECTIVES: The objectives were to determine whether IGF-I levels are reduced and to investigate determinants of GH and IGF-I in healthy overweight and obese women. DESIGN: A cross-sectional study was performed. SETTING: The study was conducted at a General Clinical Research Center. STUDY PARTICIPANTS: Thirty-four healthy women without pituitary/hypothalamic disease participated, including 11 lean [body mass index (BMI) <25 kg/m(2)], 12 overweight (BMI > or =25 kg/m(2) and <30 kg/m(2)), and 11 obese (BMI > or =30 kg/m(2)) women of comparable age (overall mean age, 30.7 +/- 7.8 yr). INTERVENTION: There was no intervention. MAIN OUTCOME MEASURES: The main outcome measures were frequent sampling (every 10 min for 24 h) for GH, peak GH after GHRH-arginine stimulation, IGF-I, IGF binding protein-3, estrone, estradiol, testosterone, free testosterone, SHBG, homeostasis model assessment of insulin resistance, and abdominal fat. RESULTS: Mean 24-h GH and peak stimulated GH were lower in overweight than lean women and lowest in obese women. Mean IGF-I levels trended lower in obese, but not overweight, compared with lean women. Free testosterone was positively associated with IGF-I (R = 0.36, P = 0.04) but not with GH measures. Visceral fat was the only determinant of mean 24-h GH (R(2) = 0.66, P < 0.0001) and of peak stimulated GH (R(2) = 0.63, P < 0.0001), and mean 24-h GH accounted for 39% of the variability of IGF-I (P = 0.0002), with an additional 28% (P < 0.0001) attributable to free testosterone levels. CONCLUSIONS: Despite a linear decrease in GH secretion and peak stimulated GH levels with increasing BMI in healthy overweight and obese women, IGF-I levels were not commensurately reduced. Androgens may contribute to this relative preservation of IGF-I secretion in overweight and obese women despite reduced GH secretion.
CONTEXT: Obesity is characterized by reduced GH secretion, but data regarding IGF-I levels and their determinants are conflicting. OBJECTIVES: The objectives were to determine whether IGF-I levels are reduced and to investigate determinants of GH and IGF-I in healthy overweight and obesewomen. DESIGN: A cross-sectional study was performed. SETTING: The study was conducted at a General Clinical Research Center. STUDY PARTICIPANTS: Thirty-four healthy women without pituitary/hypothalamic disease participated, including 11 lean [body mass index (BMI) <25 kg/m(2)], 12 overweight (BMI > or =25 kg/m(2) and <30 kg/m(2)), and 11 obese (BMI > or =30 kg/m(2)) women of comparable age (overall mean age, 30.7 +/- 7.8 yr). INTERVENTION: There was no intervention. MAIN OUTCOME MEASURES: The main outcome measures were frequent sampling (every 10 min for 24 h) for GH, peak GH after GHRH-arginine stimulation, IGF-I, IGF binding protein-3, estrone, estradiol, testosterone, free testosterone, SHBG, homeostasis model assessment of insulin resistance, and abdominal fat. RESULTS: Mean 24-h GH and peak stimulated GH were lower in overweight than lean women and lowest in obesewomen. Mean IGF-I levels trended lower in obese, but not overweight, compared with lean women. Free testosterone was positively associated with IGF-I (R = 0.36, P = 0.04) but not with GH measures. Visceral fat was the only determinant of mean 24-h GH (R(2) = 0.66, P < 0.0001) and of peak stimulated GH (R(2) = 0.63, P < 0.0001), and mean 24-h GH accounted for 39% of the variability of IGF-I (P = 0.0002), with an additional 28% (P < 0.0001) attributable to free testosterone levels. CONCLUSIONS: Despite a linear decrease in GH secretion and peak stimulated GH levels with increasing BMI in healthy overweight and obesewomen, IGF-I levels were not commensurately reduced. Androgens may contribute to this relative preservation of IGF-I secretion in overweight and obesewomen despite reduced GH secretion.
Authors: G Aimaretti; G Corneli; P Razzore; S Bellone; C Baffoni; E Arvat; F Camanni; E Ghigo Journal: J Clin Endocrinol Metab Date: 1998-05 Impact factor: 5.958
Authors: James Gibney; Troels Wolthers; Gudmundur Johannsson; A Margot Umpleby; Ken K Y Ho Journal: Am J Physiol Endocrinol Metab Date: 2005-02-22 Impact factor: 4.310
Authors: M Maccario; J Ramunni; S E Oleandri; M Procopio; S Grottoli; R Rossetto; P Savio; G Aimaretti; F Camanni; E Ghigo Journal: Int J Obes Relat Metab Disord Date: 1999-06
Authors: M Maccario; E Mazza; J Ramunni; S E Oleandri; P Savio; S Grottoli; R Rossetto; M Procopio; C Gauna; E Ghigo Journal: Clin Endocrinol (Oxf) Date: 1999-05 Impact factor: 3.478
Authors: Madelon M Buijs; Jacobus Burggraaf; Carla Wijbrandts; Marieke L de Kam; Marijke Frölich; Adam F Cohen; Johannes A Romijn; Hans P Sauerwein; A Edo Meinders; Hanno Pijl Journal: Am J Clin Nutr Date: 2003-03 Impact factor: 7.045
Authors: Polyxeni Koutkia; Bridget Canavan; Jeff Breu; Martin Torriani; John Kissko; Steven Grinspoon Journal: JAMA Date: 2004-07-14 Impact factor: 56.272
Authors: D J Brick; A V Gerweck; E Meenaghan; E A Lawson; M Misra; P Fazeli; W Johnson; A Klibanski; K K Miller Journal: Eur J Endocrinol Date: 2010-05-25 Impact factor: 6.664
Authors: Miriam A Bredella; Andrea L Utz; Martin Torriani; Bijoy Thomas; David A Schoenfeld; Karen K Miller Journal: J Appl Physiol (1985) Date: 2008-12-18
Authors: R Fornari; D Francomano; E A Greco; C Marocco; C Lubrano; F Wannenes; V Papa; V M Bimonte; L M Donini; A Lenzi; A Aversa; S Migliaccio Journal: J Endocrinol Invest Date: 2014-10-29 Impact factor: 4.256
Authors: Laura E Dichtel; Kathleen E Corey; Melanie S Haines; Mark L Chicote; Allison Kimball; Caitlin Colling; Tracey G Simon; Michelle T Long; Jad Husseini; Miriam A Bredella; Karen K Miller Journal: J Clin Endocrinol Metab Date: 2022-08-18 Impact factor: 6.134
Authors: Monica H Wojcik; Erinne Meenaghan; Elizabeth A Lawson; Madhusmita Misra; Anne Klibanski; Karen K Miller Journal: Bone Date: 2009-11-18 Impact factor: 4.398
Authors: Laura E Dichtel; Kevin C J Yuen; Miriam A Bredella; Anu V Gerweck; Brian M Russell; Ariana D Riccio; Michelle H Gurel; Patrick M Sluss; Beverly M K Biller; Karen K Miller Journal: J Clin Endocrinol Metab Date: 2014-12 Impact factor: 5.958
Authors: Joanne F Dorgan; Catherine Klifa; John A Shepherd; Brian L Egleston; Peter O Kwiterovich; John H Himes; Kelley Gabriel; Linda Horn; Linda G Snetselaar; Victor J Stevens; Bruce A Barton; Alan M Robson; Norman L Lasser; Snehal Deshmukh; Nola M Hylton Journal: Breast Cancer Res Date: 2012-07-13 Impact factor: 6.466